课题基金 / 基金详情

The significance of 53BP1 nuclear foci as a universal tumor tissue marker

The significance of 53BP1 nuclear foci as a universal tumor tissue marker
53BP1核灶作为通用肿瘤组织标志物的意义
批准号:
20590367
负责人:
NAKASHIMA Masahiro
金额:
$3.0万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

NAKASHIMA Masahiro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The presence of sporadic DNA double strand breaks (DSBs) is considered as a characteristic feature of genomic instability (GIN). It has been proposed that GIN has a crucial role during several carcinogenesis, and is associated with malignant potential of neoplasms. The presence of 53BP1 nuclear foci (NF) can be a cytologic marker for endogenous DSBs reflecting GIN. This study analyzed the level of GIN, as detected with immunofluorescence of 53BP1 expression, in a variety of resected tumors to evaluate the significance of 53BP1 expression as a universal tumor tissue marker. In results : 1) a number of 53BP1NF and abnormal type of 53BP1 expression were demonstrated in thyroid cancers, suggesting a high level of GIN ; 2) during skin carcinogenesis, GIN seems to be induced at the precancerous stage with constitutive activation of DNA damage response (DDR). Furthermore, invasive cancers exhibited abnormal 53BP1 staining, reflecting a disruption of DDR; 3) The number of 53BP1NF in uterine cervical cells appeared to increase with progression during carcinogenesis and to be significantly associated with the expression of human papilloma virus (HPV) signals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/ijc.23223
发表时间: 2008-03-01
期刊: INTERNATIONAL JOURNAL OF CANCER
影响因子: 6.4
作者: [Nakashima, Masahiro, Suzuki, Keiji, Sekine, Ichiro]
通讯作者: Sekine, Ichiro
Mutational screening of the BRCA1 gene in sporadic breast cancer in Kazakhstan population.
哈萨克斯坦人群散发性乳腺癌 BRCA1 基因突变筛查。
DOI: --
发表时间: 2011
期刊: Breast J
影响因子: 2.1
作者: [Kojima Y, Akimoto K, Nagashima Y, Ishiguro H, Kobayashi N, Matsuzaki O, Shirai S, Aoki I, Yao M, Shima H, Akilzhanova A]
通讯作者: Akilzhanova A
原爆症に関する調査研究分担報告書 共同研究課題2:原爆被爆者の免疫機能に関する研究成熟甲状腺濾胞上皮での放射線感受性と晩発性ゲノム不安定性解析
原子弹疾病联合研究报告 合作研究课题2:原子弹幸存者免疫功能研究 成熟甲状腺滤泡上皮放射敏感性和迟发型基因组不稳定性分析
DOI: --
发表时间: 2010
期刊: 平成21年度厚生労働省委託事業原爆症調査研究事業報告書
影响因子: --
作者: [S. Mitomo, C. Maesawa, S. Ogasawara, T. Iwaya, M. Shibazaki, A. Yashima-Abo, K. Kotani, H. Oikawa, E. Sakurai, N. Izutsu, K. Kato, H. Komatsu, K. Ikeda, G. Wakabayashi, T. Masuda, 中島正洋]
通讯作者: 中島正洋
DOI: --
发表时间: 2009
期刊: Hepatol Res 39
影响因子: --
作者: [Yamaguchi J, et al., Motosugi U., Eguchi S]
通讯作者: Eguchi S
75
    Mechanism of augmented phagocytic activity in liver by pioglitazone treatment
    • 批准号:
      17K08611
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2017
    • 负责人:
      NAKASHIMA Masahiro
    • 依托单位:
    Identification for radiation signature of cancer risk in irradiated thyroid
    • 批准号:
      16K08714
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2016
    • 负责人:
      NAKASHIMA Masahiro
    • 依托单位:
    Immunological properties and functions of phagocytic B cells
    • 批准号:
      26893328
    • 项目类别:
      Grant-in-Aid for Research Activity Start-up
    • 资助金额:
      $1.75万
    • 财政年份:
      2014
    • 负责人:
      NAKASHIMA Masahiro
    • 依托单位:
    Correlation analyses between 53BP1 expression and genomic instability in thyroid follicular tumors: significance as a molecular pathologic indicator
    • 批准号:
      24590414
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      NAKASHIMA Masahiro
    • 依托单位:
    国内基金
    海外基金
    CHD7通过干预53BP1表达及功能影响肠癌放射敏感性作用及机制研究
    • 批准号:
      JCZRLH202600223
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    DNA损伤修复中独立于53BP1的SHLD2功能研究
    • 批准号:
      32370774
    • 项目类别:
      面上项目
    • 资助金额:
      50万元
    • 批准年份:
      2023
    • 负责人:
      冯依力
    • 依托单位:
    CAFs源性外泌体circCUL2介导53BP1去PARylation修饰促进胰腺癌铂类耐药的机制研究
    • 批准号:
      --
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2022
    • 负责人:
      胡崇辉
    • 依托单位:
    DNA损伤应答因子53BP1调节不同阶段B细胞抗体生成多样性的机制研究
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      54万元
    • 批准年份:
      2022
    • 负责人:
      张学飞
    • 依托单位: